Chronic Kidney Disease (CKD) Market Rise Gradually at USD 19.02 billion with Top Competitors Pfizer, Amgen, Roche, Abbott, Bristol-Myers Squibb, GSK, Novartis, Sanofi, Teva Pharmaceuticals, Fresenius Group, AbbVie, Allergan and Many Others

Global Chronic Kidney Disease (CKD) Market is expected to rise gradually to an estimated value of USD 19.02 billion by 2026, registering a CAGR of 4.5% in the forecast period of 2019-2026 with the annual sales of USD 13.38 billion in the year 2018.

Global Chronic Kidney Disease (CKD) Market By Therapy Type (ACE inhibitors, Angiotensin II receptors blockers, Calcium channel blockers, Beta blockers, Diuretics others, Global chronic kidney disease), Treatment (Medications, Kidney transplantation and Dialysis), End- users (Hospitals, Homecare, Specialty Clinics, Others), Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) – Industry Trends & Forecast to 2026

Order a Free Sample Copy@ https://databridgemarketresearch.com/request-a-sample/?dbmr=global-chronic-kidney-disease-ckd-market

Chronic Kidney disease (CKD) is a serious condition identified by progressively loss of kidney function over a time. CKD is not only treatable but also a major contributing factor for death. CKD can be classified into five stages from mild stage 1 to complete kidney damage in stage 5.

According to the WHO, Global Burden of Disease (GBD) 2015, it is estimated that more than 7.00 million patient with chronic kidney disease died without approaching any medication. This data shows lack of awareness and poor availability of intervention.

Market Drivers:

• Increase in prevalence rate of hypertension, diabetes and cardiovascular diseases.
• Rising awareness about transplantation therapy and technological advancement is driving the growth of market.
• Increase in the rate of R&D initiatives is driving chronic kidney disease therapeutics market.

Global Chronic Kidney Disease (CKD) Market Key Competitors:

Few of the major competitors currently working in the Global chronic kidney diseases market are:-

• Pfizer Inc. (US),
• Amgen, Inc. (US),
• F. Hoffmann-La Roche Ltd (Switzerland),
• Abbott Laboratories (US),
• Bristol-Myers Squibb Company (US),
• GlaxoSmithKline Plc (UK),
• Novartis AG (Switzerland),
• Sanofi S.A (France),
• Teva Pharmaceutical Industries Ltd (Israel),
• Fresenius SE & Co. KGaA ( Germany),
• Kissei Pharmaceutical Co., Ltd ( Japan),
• AbbVie Inc (US),
• Allergan Plc ( Ireland) and few among others.

Inquiry Before Buying at https://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-chronic-kidney-disease-ckd-market

Global Chronic Kidney Disease (CKD) Market Competitive Analysis:

Global chronic kidney diseases market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of Global chronic kidney diseases market for global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Key Developments in the Market:

• On April 2019, FDA approved Keytruda a drug manufactured by Merck & Co., Inc. for the treatment of advanced renal cell carcinoma in the therapy area of nephrology and oncology. The drug acted as immunomodulatory. It is specifically given in the combination of axitinib which is first line treatment of patient diagnosed with renal cell carcinoma.
• On April 2018, Otsuka Pharmaceuticals Co., Ltd got FDA approval for Jynarque in the therapy area of nephrology for the treatment of autosomal dominant polycystic kidney disease. The drug is given in tablet form and it act as a selective vasopressin V2-receptor antagonist.

Table of Contents

1. Introduction

2. Market Segmentation

3. Market Overview

4. Executive Summary

5. Premium Insights

6. Global, By Component

7. Product Type

8. Delivery

9. Industry Type

10. Geography

10.1. Overview
10.2. North America
10.3. Europe
10.4. Asia-Pacific
10.5. South America
10.6. Middle East & Africa

11. Company Landscape

12. Company Profiles

13. Related Reports

Request for Detailed TOC at https://databridgemarketresearch.com/toc/?dbmr=global-chronic-kidney-disease-ckd-market

About Data Bridge Market Research:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Data Bridge Market Research

Office Number 402, Amanora Chambers,
Magarpatta Road, Hadapsar
Pune – 411028
Maharashtra, India
Email: sopan.gedam@databridgemarketresearch.com

This release was published on openPR.